NCT04865848

Brief Summary

This is a prospective, single-blind, parallel-design randomized controlled clinical trial that aims compare the effectiveness of articaine local infiltration to lidocaine inferior alveolar nerve block (IANB) for restorative treatment of primary mandibular molars (PMM). Four to 10-year-old children who needed PMM restorations are enrolled according to inclusion criteria and randomly allocated into the articaine or lidocaine group. One operator administers all local anesthesia (LA). Using the Modified Behavioral Pain Scale, 15 trained and calibrated examiners, blinded to LA type, evaluate the subjects' reactions during LA administration and treatment. Children rate their experience using the Wong-Baker FACES Pain Rating Scale. Subjects' blood pressure and pulse throughout the visit are recorded. Results are statistically analyzed using independent t-tests, Mann Whitney-U, and Repeated Measures ANOVA (P\<0.05).

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
42

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jun 2019

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 5, 2019

Completed
11 months until next milestone

First Submitted

Initial submission to the registry

May 14, 2020

Completed
12 months until next milestone

First Posted

Study publicly available on registry

April 29, 2021

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 5, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 5, 2022

Completed
Last Updated

May 9, 2024

Status Verified

May 1, 2024

Enrollment Period

2.9 years

First QC Date

May 14, 2020

Last Update Submit

May 6, 2024

Conditions

Keywords

LidocaineArticaineChildrenDentalLocalAnesthesia

Outcome Measures

Primary Outcomes (1)

  • Effectiveness of articaine local infiltration to lidocaine inferior alveolar nerve block (IANB) for restorative treatment of primary mandibular molars (PMM).

    The primary outcome measure for this study is to compare the effectiveness of articaine local infiltration to lidocaine inferior alveolar nerve block (IANB) for restorative treatment of primary mandibular molars (PMM).

    up to 24 hour later (as the parent is able to contact the principal investigator and report any issues). Numerical value of 0 is assigned to the cases that did not report any adverse events and a numerical value of 1 to reported adverse outcomes.

Secondary Outcomes (1)

  • Secondary outcome measures

    Immediately after procedure

Study Arms (2)

Mandibular infiltration dental anesthesia with Articaine

EXPERIMENTAL

Step-by-step: * Reflect tissue to expose injection site. * Orient bevel of the needle to be parallel to the bone and insert needle into mucobuccal fold * Proceed to the depth that approximates the apices of the buccal roots of the primary molars. * Aspirate. * Deposit bolus of local anesthetic slowly at a rate of 1 ml/min. * Remove needle. * A subsequent lingual infiltration is delivered. The armamentarium includes: 4% articaine HCl with 1:100,000 epinephrine (Septocaine ®, Septodont, Lancaster, Penn. USA) in 1.7 ml cartridges and 30-gauge short needle manufactured by Henry Schein® (Melville, N.Y., USA). All injections are given using a self-aspirating syringe (A-Titan, Orchard Park, N.Y., USA).

Procedure: Dental local anesthesia

Inferior Alveolar Nerve Block with Lidocaine

ACTIVE COMPARATOR

Step-by-step: * Dry injection site with gauze. * The barrel of the syringe should be directed on a plane between the two primary molars on the opposite side of the arch. It is advisable to inject a small amount of the solution as soon as the tissue is penetrated and to continue to inject minute quantities as the needle is directed toward the mandibular foramen. Insert to the depth that is adjacent to bone. * Aspirate. * Slowly inject bolus of anesthetic at a rate of 1 ml/min. * Remove needle. The armamentarium includes 2% lidocaine HCl with 1:100,000 epinephrine (Henry Schein ® Lidocaine, Novocol, Cambridge, Ontario, Canada) in 1.7 ml cartridges, as well as 27-gauge long needles manufactured by Henry Schein® (Melville, N.Y., USA). All injections are given using a self-aspirating syringe (A-Titan, Orchard Park, N.Y., USA).

Procedure: Dental local anesthesia

Interventions

Dental local anesthesia

Inferior Alveolar Nerve Block with LidocaineMandibular infiltration dental anesthesia with Articaine

Eligibility Criteria

Age4 Years - 10 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17)

You may qualify if:

  • Per patient:
  • Medical status: ASA I: a normal, healthy patient;
  • Age range: from 4 to 10 year old patients (males and females);
  • Past history of dental treatment using local anesthetic;
  • Cooperative for dental treatment (Frankel 3 or 4);
  • Obtained informed consent to participate in the study;
  • English speakers;
  • B. Per tooth:
  • Primary mandibular molar; Tooth that requires restorative dental care, including intracoronal or extracoronal restorations, due to:
  • Caries;
  • Pulp treatment (indirect pulp therapy, pulpotomy, or pulpectomy);
  • Developmental defects;
  • Tooth surface loss (erosion/attrition);

You may not qualify if:

  • A. Per patient:
  • Medical status: patients in category II,III, IV, V, VI of the ASA physical status classification system:
  • Age: younger than 4 years of age or older than 10 years of age;
  • No history of dental treatment using local anesthetic;
  • Uncooperative for dental treatment (Frankel 1 or 2);
  • Informed consent to participate in the study not obtained;
  • Non-English speakers;
  • B. Per tooth:
  • Tooth other than mandibular primary molar
  • Tooth requiring extraction

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

College of Dentistry, Univesity of Illinois at Chicago

Chicago, Illinois, 60612, United States

Location

Study Officials

  • Evelina Kratunova

    University of Illinois at Chicago

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Clinical Assistant Professor

Study Record Dates

First Submitted

May 14, 2020

First Posted

April 29, 2021

Study Start

June 5, 2019

Primary Completion

May 5, 2022

Study Completion

May 5, 2022

Last Updated

May 9, 2024

Record last verified: 2024-05

Data Sharing

IPD Sharing
Will not share

Locations